SPONSOR
Beijing 302 Hospital
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Relapsed LeukemiaRefractory LeukemiaLarge HCC PatientsStereotactic Body Radiation TherapyTranscatheter Arterial Chemoembolization
Beijing 302 Hospital is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Relapsed Leukemia, Refractory Leukemia, Large HCC Patients, Stereotactic Body Radiation Therapy.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beijing 302 Hospital
How many clinical trials has Beijing 302 Hospital sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Beijing 302 Hospital, of which 2 are actively recruiting participants. These trials cover conditions including Relapsed Leukemia, Refractory Leukemia, Large HCC Patients. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beijing 302 Hospital research focus on?
Beijing 302 Hospital clinical trials span Relapsed Leukemia, Refractory Leukemia, Large HCC Patients, Stereotactic Body Radiation Therapy, Transcatheter Arterial Chemoembolization. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Beijing 302 Hospital clinical trial?
To participate in a Beijing 302 Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beijing 302 Hospital trials with current recruitment status updated daily.
Clinical Trials by Beijing 302 Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology